Rashmi Tondon

Phase II Study of Maintenance Rucaparib in Patients With Platinum-Sensitive Advanced Pancreatic Cancer and a Pathogenic Germline or Somatic Variant in <i>BRCA1</i>, <i>BRCA2</i>, or <i>PALB2</i>

Kim A. Reiss, Rosemarie Mick, Mark H. O’Hara et al. · Journal of Clinical Oncology · 2021 · 239 citations

Medicine, Oncology, Pharmacology +14

Niraparib plus nivolumab or niraparib plus ipilimumab in patients with platinum-sensitive advanced pancreatic cancer: a randomised, phase 1b/2 trial

Kim A. Reiss, Rosemarie Mick, Ursina Teitelbaum et al. · The Lancet Oncology · 2022 · 139 citations · Full text

Medicine, Oncology, Pharmacology +9

Low Referral Rate for Genetic Testing in Racially and Ethnically Diverse Patients Despite Universal Colorectal Cancer Screening

Charles Muller, Sang Mee Lee, William Barge et al. · Clinical Gastroenterology and Hepatology · 2018 · 112 citations

Medicine, Genetics, Oncology +17

Loss-of-function variants in CTNNA1 detected on multigene panel testing in individuals with gastric or breast cancer

Dana Clark, Scott T. Michalski, Rashmi Tondon et al. · Genetics in Medicine · 2020 · 43 citations · Full text

Medicine, Genetics, Oncology +17

Molecular and cytogenomic profiling of hepatic adenocarcinoma expressing inhibinA, a mimicker of neuroendocrine tumors: proposal to reclassify as "cholangioblastic variant of intrahepatic cholangiocarcinoma”

David R. Braxton, Debra Saxe, Nevena Damjanov et al. · Human Pathology · 2017 · 38 citations

Medicine, Oncology, Pathology +17